Literature DB >> 8594054

Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia.

W H Lee1, G M Wang, L B Seaman, S J Vannucci.   

Abstract

Insulin-like growth factor I (IGF-I) is an anabolic pleiotrophic factor essential for postnatal rat brain development, especially during the first 21 days, the "critical growth period." Cerebral hypoxic-ischemic insults occurring during the perinatal period can result in neuronal necrosis and permanent brain damage. To understand the regulation of the action of IGF-I in response to such a metabolic insult, we investigated the gene expression of IGF-I, type I IGF receptor, IGF binding protein (IGFBP)2, and IGFBP5 during the first 72 h after hypoxia-ischemia in the immature rat. At 1 h of recovery, messenger RNA (mRNA) levels of all IGF system components were decreased throughout the hemisphere ipsilateral to the carotid artery ligation. This decrease is more pronounced at 24 h of recovery, especially in areas vulnerable to hypoxic-ischemic injury, such as the thalamus and hippocampus. At 72 h of recovery, although IGFBP2 and type 1 IGF receptor mRNA levels remain suppressed, gene expression of both IGF-I and IGFBP5 was activated in reactive astrocytes.Therefore, during the critical growth period in rats, the transcriptional levels of all IGF system components are extremely sensitive to metabolic perturbations associated with cerebral hypoxia-ischemia. The immediate decrease in IGF-I gene expression may be partially responsible for the impending neuronal death and selective vulnerability of myelinogenesis during the perinatal period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8594054     DOI: 10.1097/00004647-199603000-00007

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  19 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Perinatal hypoxia-ischemia decreased neuronal but increased cerebral vascular endothelial IGFBP3 expression.

Authors:  W H Lee; G M Wang; X L Yang; L B Seaman; S I Vannucci
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

3.  Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

Authors:  S A Loddick; X J Liu; Z X Lu; C Liu; D P Behan; D C Chalmers; A C Foster; W W Vale; N Ling; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 4.  Generating new neurons to circumvent your fears: the role of IGF signaling.

Authors:  R C Agis-Balboa; A Fischer
Journal:  Cell Mol Life Sci       Date:  2013-03-30       Impact factor: 9.261

5.  Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults.

Authors:  Raymond P Rothstein; Steven W Levison
Journal:  Dev Neurosci       Date:  2005 Mar-Aug       Impact factor: 2.984

Review 6.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

7.  Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1.

Authors:  Juan C Chavez; Joseph C LaManna
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

8.  Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas.

Authors:  Xuequn Chen; Maria Dolors Sans; John R Strahler; Alla Karnovsky; Stephen A Ernst; George Michailidis; Philip C Andrews; John A Williams
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

9.  Insulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes.

Authors:  Robert J Romanelli; Kedar R Mahajan; Clifton G Fulmer; Teresa L Wood
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

Review 10.  IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.

Authors:  Jian Guan; Peter D Gluckman
Journal:  Br J Pharmacol       Date:  2009-05-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.